Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HRT: developments in therapy.

M C Ellerington1, S I Whitcroft, M I Whitehead

  • 1Academic Department of Obstetrics and Gynaecology, King's College School of Medicine and Dentistry, London, UK.

British Medical Bulletin
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.

Clinical endocrinology·2004
Same author

Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised women.

Maturitas·2002
Same author

Patient acceptability of and tolerance to a placebo intravaginal ring in hysterectomized women: a pilot study.

Climacteric : the journal of the International Menopause Society·2002
Same author

Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?

Climacteric : the journal of the International Menopause Society·2001
Same author

Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.

Metabolism: clinical and experimental·2000
Same author

Endometrial assessment re-visited.

British journal of obstetrics and gynaecology·1999
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Hormone Replacement Therapy (HRT) has evolved beyond oral estrogen. Newer progestogen therapies, including non-oral routes and novel compounds, aim to improve safety and patient compliance, though efficacy requires further study.

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology
  • Gynecology

Background:

  • Hormone Replacement Therapy (HRT) has utilized various estrogen forms for 50 years, with limited changes in administration until recently.
  • Oral estrogen remains the primary HRT route, but concerns about endometrial carcinoma risk led to adding progestogens.
  • Conventional progestogens can cause side effects and undesirable metabolic changes, driving the search for alternatives.

Purpose of the Study:

  • To review advancements in Hormone Replacement Therapy (HRT) administration and progestogen development.
  • To explore non-oral delivery systems and novel compounds to mitigate progestogen side effects and metabolic concerns.
  • To assess the potential of new HRT strategies in addressing issues like withdrawal bleeding and overall efficacy.

Main Methods:

Related Experiment Videos

  • Review of historical and current practices in estrogen and progestogen administration for HRT.
  • Examination of non-oral delivery systems, including transdermal patches and intrauterine devices.
  • Discussion of new progestogen compounds and continuous administration regimens.

Main Results:

  • Development of non-oral estrogen and progestogen delivery systems (transdermal, intrauterine).
  • Introduction of new progestogens and compounds like tibolone to improve metabolic profiles.
  • Exploration of continuous progestogen administration to manage withdrawal bleeding.

Conclusions:

  • Non-oral HRT routes and novel progestogens offer potential benefits in minimizing side effects and improving patient experience.
  • Continuous progestogen regimens may overcome issues with withdrawal bleeding, enhancing compliance.
  • Further research is needed to confirm the long-term efficacy of these newer HRT strategies compared to conventional treatments.